Stay updated with breaking news from Khary edwards. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
THURSDAY, March 2, 2023 (HealthDay News) Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) are beneficial for treating type 1 diabetes mellitus (T1DM), with similar reductions in glycated hemoglobin A1c (HbA1c), according to a study recently published in the Journal of Clinical Endocrinology & Metabolism. Khary Edwards, M.D., from the University of ....
Two classes of drugs prescribed off-label for some patients with Type 1 diabetes can provide significant benefits but also come with health concerns, according to a study by UT Southwestern Medical Center researchers. ....